MARKET

BMRA

BMRA

Biomerica Inc
NASDAQ
2.490
+0.050
+2.05%
After Hours: 2.490 0 0.00% 16:10 05/22 EDT
OPEN
2.420
PREV CLOSE
2.440
HIGH
2.490
LOW
2.390
VOLUME
8.45K
TURNOVER
--
52 WEEK HIGH
4.600
52 WEEK LOW
1.866
MARKET CAP
7.69M
P/E (TTM)
-1.5675
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BMRA last week (0511-0515)?
Weekly Report · 5d ago
Weekly Report: what happened at BMRA last week (0504-0508)?
Weekly Report · 05/11 09:08
Weekly Report: what happened at BMRA last week (0427-0501)?
Weekly Report · 05/04 09:08
Biomerica inFoods IBS real-world effectiveness study accepted for DDW 2026 presentation
PUBT · 04/29 12:19
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Barchart · 04/29 07:19
Weekly Report: what happened at BMRA last week (0420-0424)?
Weekly Report · 04/27 09:08
Weekly Report: what happened at BMRA last week (0413-0417)?
Weekly Report · 04/20 09:08
Biomerica announces MAC confirms inFoods IBS test is eligible for coverage
TipRanks · 04/16 13:12
More
About BMRA
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients in the diagnosis of various diseases, food intolerances, and other medical complications. The Company’s diagnostic test kits can also be used to measure or detect the presence and levels of specific bacteria, hormones, antibodies, antigens and other substances, which may exist in the human body in small concentrations. Its range of medical diagnostic products is sold in two markets: clinical laboratories and point-of-care settings. The Company’s diagnostic-guided therapy (DGT) product is developed on the inFoods technology platform, which is designed to aid in the management of gastrointestinal conditions such as irritable bowel syndrome (IBS) and other inflammatory diseases.

Webull offers Biomerica Inc stock information, including NASDAQ: BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.